Skip to content

Efficacy and safety analysis of laparoscopic exploration of common bile duct with primary suturing combined with pancreatic duct stenting in the treatment of common bile duct stones complicated with gallbladder stones.

Efficacy and safety analysis of laparoscopic exploration of common bile duct with primary suturing combined with pancreatic duct stenting in the treatment of common bile duct stones complicated with gallbladder stones.

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078727
Enrollment
Unknown
Registered
2023-12-16
Start date
2024-01-01
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common bile duct stones

Interventions

Pancreatic duct stent group:Pancreatic duct stent drainage following laparoscopic common bile duct exploration.
T-tube drainage group:T-tube drainage following laparoscopic common bile duct exploration.

Sponsors

Chengdu Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Preoperatively confirming the presence of common bile duct stones combined with gallbladder stones through radiological examinations; (2) Common bile duct diameter = 8 mm; (3) Overall good health and well-functioning vital organs, capable of tolerating general anesthesia; (4) Voluntarily participating in the study with informed consent.

Exclusion criteria

Exclusion criteria: Patients preoperatively or intraoperatively confirmed to have (1) acute suppurative obstructive cholangitis, (2) intrahepatic bile duct stones, (3) biliary tumors, (4) biliary anomalies, or the formation of gastrointestinal fistulas, or (5) patients unable to tolerate surgery.

Design outcomes

Primary

MeasureTime frame
Operation time;bile leakage;Operative blood loss;bile peritonitis;Stent-related complications;

Secondary

MeasureTime frame
age;sex;TBil(total bilirubin);direct bilirubin;hemameba;Choledocholithiasis size;alanine aminotransferase;aspartate aminotransferase;Second operation;Body Mass Index;

Countries

China

Contacts

Public ContactTao He

Chengdu Second People's Hospital

hetao9208@outlook.com+86 151 8430 2720

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026